[NKTR] YoY Quarter Result on 30-Sep-2021 [#Q3]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -3.34%
YoY- -19.45%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 24,124 24,144 23,625 24,921 30,033 29,218 27,762 -2.31%
PBT -37,048 -45,898 -59,204 -129,594 -108,565 -98,486 -97,043 -14.81%
Tax 9 -61 -155 112 21 322 -900 -
NP -37,057 -45,837 -59,049 -129,706 -108,586 -98,808 -96,143 -14.67%
Tax Rate - - - - - - - -
Total Cost 61,181 69,981 82,674 154,627 138,619 128,026 123,905 -11.08%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -153.61 -189.85 -249.94 -520.47 -361.56 -338.18 -346.31 -12.66%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.18 -0.24 -0.31 -0.70 -0.61 -0.56 -0.56 -17.22%
EPS Diluted -0.18 -0.24 -0.31 -0.70 -0.61 -0.56 -0.56 -17.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.